Limbal Stem Cell Deficiency
18
4
4
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
5.6%
1 terminated out of 18 trials
83.3%
-3.2% vs benchmark
6%
1 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (18)
Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Limbal Stem Cell Deficiency
Association Between Limbal Function and Tear Proteomics in Chronic Ocular Diseases: Focusing on Glaucoma
Autologous Cultured Corneal Epithelium (CECA) for the Treatment of Limbal Stem Cell Deficiency
Limbal Stem Cell Deficiency (LSCD) Treatment With Cultivated Stem Cell (CALEC) Graft
Limbal Epithelial Stem Cell Transplantation: a Phase II Multicenter Trial
Implementation of a Protocol for the Transdifferentiation of Buccal Mucosal Epithelium Into Corneal Epithelium
Validation of Human Drugs Target of Repurposed Drugs and Novel Therapies
Allogeneic ABCB5-positive Limbal Stem Cells for Treatment of LSCD
Cultivated Autologous Oral Mucosal Epithelial Transplantation
Corneal Epithelial Allograft From Living-related Donor for LSCD
Corneal Epithelial Autograft for LSCD
Biodegradable Synthetic Scaffold as a Substitute for hAM in Limbal Epithelial Cells Transplant in LSCD Patients
ABCB5 as a Prognostic Marker in Survival of Cultivated Limbal Stem Cell Transplantation
Transplantation of Autologous Oral Mucosal Epithelial Stem Cell Sheet for Treating Limbal Stem Cell Deficiency Disease
Clinical Trial on the Effect of Autologous Oral Mucosal Epithelial Sheet Transplantation
Multicenter Study of CAOMECS Transplantation to Patients With Total Limbal Stem Cell Deficiency
Cultivated Stem Cell Transplantation for the Treatment of Limbal Stem Cell Deficiency
Autologous Transplantation of Cultivated Limbal Stem Cells on Amniotic Membrane in Limbal Stem Cell Deficiency (LSD) Patients